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Abstract
Purpose PR interval prolongation > 200 ms resulting in the diagnosis of first-degree atrioventricular block (AVB1) is caused by a
delay in the AV nodal/His conduction and/or the right intra-atrial conduction (RIAC). The aim of the study was to assess the
prevalence of AVB1 due to RIAC delay (AVB1 with normal AH and HV) in patients with atrial fibrillation (AF) and atrial flutter
(AFlu).
Methods We included 1067 consecutive patients (33% female, age 63 ± 13 years) referred for catheter ablation of AF (AF-group)
(453 patients), AF and AFlu (136 patients), AFlu (292 patients), and AVNRT/AVRT (186 patients). AH-, HV-, PR-interval, and
P-wave duration were measured on the 12-lead ECG and the intracardiac electrograms in sinus rhythm. RIAC delay was defined
as a prolonged PR interval > 200 ms with normal AH and HV intervals.
Results The prevalence of AVB1 is higher in patients with AFlu (41%) and AF (21%) and patients with both arrhythmias (30%)
as compared with a reference group (8%) of patients with AVNRT/AVRT. AVB1 was due to RIAC delay in 42 of 67 patients
(63%) in the AF-group, in 37 of 96 patients (39%) in the AFlu-group, and in 17 of 36 patients (47%) in the AF/AFlu group,
respectively. AV nodal conduction delay was more common in AFlu patients compared with AF patients.
Conclusion RIAC delay is a common underlying cause of AVB1 in patients with AF and AFlu. These findings may impact the
prescription of antiarrhythmic and AV-nodal blocking drugs.
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1 Purpose
First-degree atrioventricular block (AVB1), defined as PR
interval longer than 200 ms, is frequently encountered in
clinical practice and generally considered benign [1]. Since
the PR interval is measured between the onset of the Pwave
and of the QRS-complex on the 12-lead ECG, it is depen-
dent on both, the right intra-atrial conduction (RIAC) and
the AV conduction over the AV node and the His bundle.
The electrical and structural remodeling of the atrium ob-
served in patients with AF [2, 4] and cavotricuspid isthmus
(CTI)-dependent AFlu [3] may result in (right) atrial con-
duction delay influencing the PR interval measurements.
The exact contribution of the RIAC interval on the PR in-
terval commonly used for electrical characterization of the
heart has not been systematically investigated in patients
with AF and AFlu. Furthermore, the prevalence of RIAC
delay defined as AVB1 with normal AH and HV intervals is
unknown.
The aim of this study was to assess the prevalence of AVB1
due to RIAC delay by standard invasive electrophysiological
measurements in patients referred for catheter ablation of AF
and AFlu. In addition, patients undergoing catheter ablation of
AVNRT or AVRT were analyzed as a reference group
representing patients without any known or suspected right
atrial myocardial conduction disease.
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2 Methods
We included 1067 consecutive patients undergoing an electro-
physiological study for ablation of AF (AF-group), CTI-
dependent AFlu (AFlu-group), and AVNRT/AVRT (refer-
ence-group). Diagnosis of CTI-dependent AFlu was performed
by positive entrainment maneuver from the CTI in case of
persistent flutter in the electrophysiology lab and based on 12-
lead documentation showing a negative saw-tooth waves in
inferior leads and positive waves in V1. Patients with docu-
mented AF in the AFlu-group and documented AFlu in the
AF-group were combined in an AF/AFlu-group.
Measurements on the 12-lead ECG and intracardiac electro-
grams using standard quadripolar and decapolar catheters with
5 mm and 2 mm interelectrode spacing (Abbot Medical and
Biosense Webster, USA) were performed by two experienced
technicians at the end of the procedure in sinus rhythm on the
EP recording system (Sensis, Siemens, Germany). Intervals
were defined as follows: atrium-His (AH) interval—onset of
atrial signal to onset of His-deflection on the His recording
(normal: 60–125 ms), His-ventricle (HV) interval—onset of
His-deflection to onset of QRS interval (normal: 35–55 ms),
P-wave duration—onset to offset of the P wave of all 12 leads,
PR interval—beginning of P wave to first deflection of QRS,
QRS duration—onset to offset of the QRS complex of all 12
leads, and RIAC—onset of P wave to onset of the atrial signal
on His catheter. RIAC delay was defined as a prolonged PR
interval > 200 ms with normal AH and HV intervals. The def-
inition of persistent and paroxysmal AF was performed accord-
ing to the AHA/ACC/HRS guidelines [5]. Patients treated with
antiarrhythmic drugs (class IC and class III) were excluded.
3 Results
A total of 858 patients (33% female, 63 ± 13 years) were ana-
lyzed. Thereof, 237 (28%), 319 (37%), 120 (14%), and 182
(21%) were included in the AFlu-group, the AF-group, the AF/
AFlu-group, and the reference-group, respectively. Baseline data
were significantly different between the groups (Table 1). Data of
an age- and sex-matched analysis are shown in supplemental
Table 1 and 2. The baseline data of the patients with paroxysmal
and persistent AF were not different. AVB1 was present in 67
patients (21%) of the AF-group, in 96 patients (41%) of the
AFlu-group, in 36 patients (30%) of the AF/AFlu-group, and
in 15 patients (8%) of the reference-group. In the patients with
AVB1, RIAC delay was observed in 42 of 67 patients (63%) in
the AF-group, in 37 of 96 patients (39%) in the AFlu-group, and
in 17 of 36 patients (47%) in AF/AFlu-group. The difference in
RIAC delay between the AF-group (63%) and the AFlu-group
(39%) was statistically significant (p = 0.013). PR interval pro-
longation was rare in the reference group, but if present was also
due to RIAC delay in 40%. In patients without AVB1, the
prevalence of a RIAC time > 45 ms [6] was 57%, 63%, 63%,
and 27% in the AF-group, the AF/AFlu-group, the AFlu-group,
and the reference-group, respectively.
4 Discussion
Whereas it is known that AV conduction is determined by the
RIAC and the conduction over the AV node and the His bun-
dle, its dispersion has never been quantified in such a large
cohort of patients with AF and CTI-dependent AFlu. The
main findings of this analysis are as follows:
1. The prevalence of AVB1 is high in patients with AFlu and
AF and a combination of both arrhythmias as compared
with a reference group of patients with AVNRT/AVRT.
2. The prevalence of RIAC delay as the cause of PR prolon-
gation is significant in patients with AF, AFlu, and a com-
bination of AF and AFlu, with the highest proportion
observed in the AF group.
In previous studies, PR prolongation has been shown to be
independently associated with the risk of developing AF [7]
and all-cause mortality [8]. However, the individual contribu-
tion of the RIAC and the AV nodal conduction on the PR
interval have not been investigated in this context. In conse-
quence, whether the reported risk for these events is due to
right atrial conduction delays or the delay within the AV node
is unclear. To address this lack of knowledge, we analyzed
patients with AF and AFlu to investigate whether differences
in the site of the conduction impairment (RIAC or AV nodal)
can be observed for these groups.
In our patients, the prevalence of AVB1 defined by PR pro-
longation > 200 ms was relatively high in patients with AF
(21%) and even higher in CTI-dependent AFlu (41%).
Interestingly, RIAC delay as a measure of solely right intra-
atrial conduction delay (without AV conduction delay) was ob-
served more often in patients with AF than with AFlu, whereas
the AFlu-group showed an AVB1 more often due to AV nodal
conduction delay. This observation is in contrast to the only other
study investigating electrophysiological difference in the right
atrium between patients with AFlu and AF [9]. Medi et al. re-
ported that patients with AFlu showed more advanced remodel-
ing with slowed conduction and lower voltage areas especially in
the posterior right atrium than with AF. However, this was a
small study with only 10 and 13 patients in the AFlu and AF
group, respectively, and the baseline details such as type of AF
and prescription of AV blocking agents was not reported, which
might explain the differences, as well as an inhomogeneous dis-
tribution of a right atrial remodeling (Fig. 1).
In addition, our findings may have additional clinical impli-
cations based on the differentiation between AV nodal-related
versus RIAC-related conduction delay. For example, since the
J Interv Card Electrophysiol
administration of negative dromotropic and/or antiarrhythmic
drugs performed with caution in patients with AV nodal conduc-
tion disturbances [8], our findings show that the use of these drug
therapies should not be limited because of AVB1 per se because
the cause of AVB1 is a delay in the RIAC and not in theAV-node
or His bundle in a significant number of cases. In conclusion, if
the knowledge of the location of the atrioventricular conduction
delay in patients with AVB1 is of clinical importance, an electro-
physiological study might be indicated.
Based on our observations, one could hypothesize that AF
results in more pronounced RA remodeling resulting in an in-
crease of conduction delay compared with AFlu. This is in line
with a basic research study in neonatal rat ventricular myocytes
showing that irregular (AF-like) compared regular electrical
activation (AFlu-like) results in a phenotype consistent with
findings in atrial cardiomyocytes from AF patients [10].
Whether this knowledge about the differences in right atrial
conduction delay should be used, e.g., in additional right atrial
0%
10%
20%
30%
40%
50%
60%
70%
AF-group
n = 319
AF/AFlu-group
n = 120
AFlu-group
n = 237
% RIAC-delay of AVBI pts.
% AVBI pts. 
Fig. 1 Bar chart of prevalence of
AV-block first degree (AVBI) and
right atrial conduction (RIAC)
delay in patients with atrial fibril-
lation (AF), atrial flutter (AFlu),
and the patients with both ar-
rhythmias, AF and AFlu. The
dark blue bar represents the per-
centage prevalence of AVBI in the
overall cohort of the respective
group; the light blue bar repre-
sents the percentage prevalence of
RIAC delay in the cohort of AVBI
patients of the respective group
Table 1 Baseline data and electrocardiographic data of the patients
All groups
n = 858
AF-group n = 319
(37%)
AF/AFlu-group n = 120
(14%)
AFlu-group n = 237
(28%)
Reference-group n = 182
(21%)
p value
Baseline data
Age (years) 61 ± 11 §, ‡, # 67 ± 11 ‡, † 68 ± 12 §,* 55 ± 19 #, *, † < 0.001
BMI (kg/m2) 28 ± 5 # 28 ± 5 † 28 ± 5 * 26 ± 6 #, *,† < 0.001
Female, n (%) 79 (25) 33 (28) 36 (15) 99 (54) < 0.001
Paroxysmal AF, n (%) 195 (61) 51 (43) n. a. n. a. n. a.
Hypertension, n (%) 194 (61) 67 (56) 95 (40) 59 (32) < 0.001
Beta blockers, n (%) 239 (75) 86 (72) 109 (46) 47 (26) < 0.001
Electrocardiographic data
AH interval (ms) 84 ± 25 § 87 ± 28 ¥ 100 ± 42 §, ¥,* 86 ± 26 * < 0.001
HV interval (ms) 43 ± 8 §, # 45 ± 9 † 48 ± 11 §, 41 ± 7 #, *, † < 0.001
P-wave duration (ms) 125 ± 19 §, # 131 ± 21 † 137 ± 27 §, * 108 ± 15 #, *, † < 0.001
PR interval (ms) 179 ± 31 §, # 186 ± 37 ¥, † 202 ± 48 §, ¥, * 165 ± 30 #, *, † < 0.001
RIAC interval (ms) 52 ± 17 # 54 ± 21, † 55 ± 22 * 38 ± 15 #,*, † < 0.001
AH prolonged, n (%) 18 (6) 13 (11) 44 (19) 9 (5) < 0.001
HV prolonged, n (%) 18 (6) 8 (7) 38 (16) 4 (2) < 0.001
AVBI, n (%) 67 (21) 36 (30) 96 (41) 15 (8) < 0.001
RIAC delay, n (%)
(overall)
42 (13) 17 (14) 37 (16) 6 (3) 0.001
RIAC delay, n (%)
(AVBI)
42 (63) § 17 (47) 37 (39) § 6 (40) 0.021
Values are shown as mean ± standard deviation. P value from ANOVA, with post-hoc Tukey test: § p < 0.05 between AF and AFlu; # p < 0.05 between
AF and Reference-group; ‡ p < 0.05 between AF and AF/AFlu –group; *p < 0.05 between AFlu and reference-group; ¥p < 0.05 between AFlu and AF/
AFlu -group; †p < 0.05 between AF/AFlu and reference-group
J Interv Card Electrophysiol
ablation strategies in patients with persistent AF or to perform
AF ablation in patients with AFlu and RIAC delay due to the
increased risk for AF [5] is an interesting research question that
might be addressed in future studies. In this context, we await
the results of the CRAFT study (https://clinicaltrials.gov/ct2/
show/NCT03401099) investigating the impact of cryoballoon
PVI in patients referred for catheter ablation of CTI-dependent
flutter without previously documented AF.
5 Limitations
The four groups differ with regard to baseline data. This is
relevant especially for age, which was shown to correlate with
the atrial conduction [11]. However, since the AFlu group was
older than the AF group but the delay was more prevalent in the
AF group, an older age in the AF group might not decrease this
difference. The age- and sex-matched analyses shown in the
supplemental tables confirm this observation. Furthermore, de-
spite studying a large sample of 858 patients, the number of
patients with RIAC delay in the different groups is relatively
small. This was addressed by critical interpretation of the ob-
servations. One further limitation is the measurement of the PR
interval itself and the absolute definition of a cut-off of 200 ms
without addressing the heart rate dependency. Beta blockers
were continued during the study; this can have an effect on
the AV conduction. However, we focused our view on the
RIAC delay, which by definition excluded patients with AH
and/or HV extension. Also, despite not being observed or re-
ported in other studies, an impact of the CTI ablation line on the
PR interval cannot be excluded. Finally, our findings are obser-
vational in nature. Whether the underlying mechanisms can be
explained mainly by remodeling associated with the respective
arrhythmias, the predisposing risk factors, or whether specific
molecular mechanisms such as connexin distribution or dysreg-
ulation are present [12], are currently unknown and requires
further investigations.
6 Conclusion
In conclusion, PR prolongation has a high prevalence in pa-
tients with AFlu and AF but frequently represents what we
could call a “pseudo”-AVB1. In clinical practice, RIAC delay
should be considered as a potential cause of AVB1 in any
patient with PR prolongation and especially in patients with
AF. The presented findings may help to discriminate the rea-
son for AVB1 in patients with AFlu and AF and may have
clinical implications when prescribing antiarrhythmic drugs,
betablockers, or calcium-channel blockers or planning cathe-
ter ablation.
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